These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 16892789

  • 1. Onset and duration of protection against exercise-induced bronchoconstriction by a single oral dose of montelukast.
    Pearlman DS, van Adelsberg J, Philip G, Tilles SA, Busse W, Hendeles L, Loeys T, Dass SB, Reiss TF.
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):98-104. PubMed ID: 16892789
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pretreatment with albuterol versus montelukast for exercise-induced bronchospasm in children.
    Raissy HH, Harkins M, Kelly F, Kelly HW.
    Pharmacotherapy; 2008 Mar; 28(3):287-94. PubMed ID: 18294107
    [Abstract] [Full Text] [Related]

  • 8. Effect of montelukast or salmeterol added to inhaled fluticasone on exercise-induced bronchoconstriction in children.
    Fogel RB, Rosario N, Aristizabal G, Loeys T, Noonan G, Gaile S, Smugar SS, Polos PG.
    Ann Allergy Asthma Immunol; 2010 Jun; 104(6):511-7. PubMed ID: 20568384
    [Abstract] [Full Text] [Related]

  • 9. Time-effect of montelukast on protection against exercise-induced bronchoconstriction.
    Peroni DG, Pescollderungg L, Sandri M, Chinellato I, Boner AL, Piacentini GL.
    Respir Med; 2011 Dec; 105(12):1790-7. PubMed ID: 21865022
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction.
    Vidal C, Fernández-Ovide E, Piñeiro J, Nuñez R, González-Quintela A.
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):655-8. PubMed ID: 11428738
    [Abstract] [Full Text] [Related]

  • 12. Baseline predictors of placebo response in exercise-induced bronchoconstriction (EIB): pooled regression analysis >from three studies of montelukast in EIB.
    Philip G, Swern AS, Smugar SS, Pearlman DS.
    J Asthma; 2010 Oct; 47(8):935-41. PubMed ID: 20858150
    [Abstract] [Full Text] [Related]

  • 13. Comparative effects of long-acting beta2-agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma.
    Coreno A, Skowronski M, Kotaru C, McFadden ER.
    J Allergy Clin Immunol; 2000 Sep; 106(3):500-6. PubMed ID: 10984370
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. A randomized, double-blind trial. Exercise Study Group.
    Edelman JM, Turpin JA, Bronsky EA, Grossman J, Kemp JP, Ghannam AF, DeLucca PT, Gormley GJ, Pearlman DS.
    Ann Intern Med; 2000 Jan 18; 132(2):97-104. PubMed ID: 10644288
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma.
    Mastalerz L, Gawlewicz-Mroczka A, Nizankowska E, Cmiel A, Szczeklik A.
    Clin Exp Allergy; 2002 Sep 18; 32(9):1360-5. PubMed ID: 12220476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.